Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

UNKNOWN × Adenocarcinoma × Dermatologic × Clear all

Phase

Status

Sponsor Class

INDUSTRY 14 UNKNOWN 1 OTHER 1 NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1 Thoracic 1 Gynecologic 1 Genitourinary 1 Gastrointestinal 1 Dermatologic 1

Conditions

Melanoma 4 Skin Neoplasms 2 Urinary Bladder Neoplasms 1 Stomach Neoplasms 1 Skin Diseases 1 Ovarian Neoplasms 1 Neoplasms 1 Hutchinson's Melanotic Freckle 1 Colorectal Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Adenocarcinoma 1

Interventions

pembrolizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02346955 2020-08-27

MK-6018-001

KitovPharma

Phase 1 Terminated

DermatologicGastrointestinalGenitourinaryGynecologicThoracic

Adenocarcinoma, Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Melanoma, Neoplasms, Ovarian Neoplasms, Stomach Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡